Transcatheter valve interventions: playground for cardiologists or cardiac surgeons? The cardiologist's view.

Historically, the only interventional management option for valve pathology was cardiac surgery. However, the rapid evolution of transcatheter valve interventions has catapulted cardiologists into a central role in the management of these patients. A welcome consequence of this rapid change in the landscape has been the fostering of new and improved relationships between cardiologists and cardiac surgeons and the formulation of "Heart Teams" to facilitate patient management. We believe that the cardiologist, who already utilises many of the clinical and procedural skills required to manage this complex group of patients, is optimally placed to be the central figure within the multidisciplinary team, and to deliver these treatments with the ultimate aim of achieving the best possible patient outcomes.

[1]  Antonio Colombo,et al.  The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? , 2015, European heart journal.

[2]  C. Di Mario,et al.  Valve-in-valve transcatheter aortic valve implantation for failing surgical aortic stentless bioprosthetic valves: A single-center experience. , 2015, The Journal of thoracic and cardiovascular surgery.

[3]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[4]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[5]  Alistair C. Lindsay,et al.  Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in-hospital outcomes of an apically tethered device. , 2015, Journal of the American College of Cardiology.

[6]  M. Mack,et al.  Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy , 2015, Circulation.

[7]  W. O’Neill,et al.  Transcatheter tricuspid valve intervention: the next frontier. , 2015, Journal of the American College of Cardiology.

[8]  H. Gray,et al.  Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. , 2015, Circulation.

[9]  L. Martinelli,et al.  Cardiac rehabilitation and mid-term follow-up after transcatheter aortic valve implantation , 2014, Journal of geriatric cardiology : JGC.

[10]  Nancy M Albert,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.

[11]  P. Wenaweser,et al.  Transcatheter aortic valve implantation: the transfemoral access route is the default access. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  S. Blankenberg,et al.  Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[14]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.